FDA Officials Lay Out Vision for Agency

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the agency in a JAMA Viewpoint .

Marty Makary, MD, MPH, and Vinay Prasad, MD, MPH, focused on five key areas: speeding approval times while diminishing "industry capture," an increased focus on regulating food, greater use of "big data," tackling financial toxicity, and boosting use of artificial intelligence (AI).

"At the FDA, we will examine the role of ultraprocessed foods, food additives, and environmental toxins, the introduction of which has paralleled the epidemic of chronic diseases," they wrote. "We will transition from a purely reactionary healthcare system to one that is proactive, intellectually curious about underlying causes, and financially aligned to pro